1 / 24

NANS I 3 Steve Adler December 6, 2012

NANS I 3 Steve Adler December 6, 2012. Indications for Use. U.S. Infumorph Europe Morphine and Baclofen. Accuracy. Definition: Accuracy refers to the correctness of a single measurement. Accuracy is determined by comparing the measurement against the true or accepted value.

cardea
Download Presentation

NANS I 3 Steve Adler December 6, 2012

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. NANS I3 Steve Adler December 6, 2012

  2. Indications for Use • U.S. • Infumorph • Europe • Morphine and Baclofen

  3. Accuracy Definition: Accuracy refers to the correctness of a single measurement. Accuracy is determined by comparing the measurement against the true or accepted value. For our purposes, the true or accepted value is the programmed dose

  4. Examples of Poor Accuracy

  5. Introduction • Product development process for accurate pump • Requirements • Solutions – valve gated technology • Bench or verification tests • Clinical study results • Clinical significance, next steps

  6. Design Considerations for Accurate (Precise, Durable) Pump • Prior pumps had shortcomings • Important design considerations • Accuracy of drug delivery • Accuracy of reported volume in reservoir • Consistency of amount received by the patient over time • Limit any variation in flow rate due to programmed dose, battery age, reservoir volume, temperature or pressure • Ability to accurately deliver micro-doses • No variation in device performance over a wide range of concentrations and compounds

  7. Product Development • New technology was required to design a pump with a an accurate dosing mechanism • The challenges were to design • A completely different flow regulating mechanism • Electronics that would allow precise timing and provide redundant safety checks • A power supply with exceptional longevity • Communication capabilities that were insusceptible to interference and able to prevent programming errors

  8. Prometra Pump • Dose Accuracy 98% • No temp, pressure, reservoir volumeeffects • Longevity >10 years • Designed to deliver any compound • Can deliver micro-doses

  9. Dose RegulationValve-Gated Dosing Chamber

  10. Bench Testing • Extensive bench testing was performed to confirm overall accuracy, as well as accuracy under a variety of conditions. • Pressure extremes • Temperature extremes • Various programmable rates • Various reservoir fill levels • Various environmental exposures • Temperature cycling • Electric shock exposure • Vibration testing • Multiple sterilization cycles • Drug flow accuracy was within specification in each testing scenario.

  11. Bench Testing Results

  12. Ongoing Life Testing

  13. PUMP Clinical Study: Accuracy Results Accuracy Results (%) Number of Refills = 2,073 Number of Patients = 148 • Accuracy was calculated as the delivered (volumetrically determined) to programmed (DP) drug volume ratio • Numerator: sum of delivered drug volumes over all (scheduled and unscheduled) valid fill/refill sessions per patient • Denominator: sum of programmed drug volumes over all (scheduled and unscheduled) valid fill/refill sessions per patient • Overall accuracy is calculated by averaging the per patient DP ratios

  14. Accuracy by Flow Rate • Flow rate range: 0-1.5 mL/day • No statistically significant differences between flow rate categories

  15. Accuracy by Months Post-Implantation • No statistically significant differences between any of the time-points

  16. Accuracy by Residual Volume • (12.0-16.0] was lower than [0.0-4.0] (p=0.0119) • (16.0-20.0] was lower than all other categories (p<0.0001) • Mean accuracy was 100% in the lowest residual volume category (0.0, 4.0].

  17. Accuracy by Concentration • Morphine concentration range: 1-50 mg/mL • No significant differences between concentration categories • No pump failures or other complications occurred related to drug concentration

  18. Ongoing Continued EvaluationLSU Health Science Center

  19. Durability and Longevity • The only moving parts are the valves • Fewer moving parts and a simpler design mean less opportunity for complications • The valves require very little energy • Promotes longer battery life, requiring fewer replacement surgeries over the course of a patient’s IT therapy.

  20. Accuracy With Other Drugs? • Proper function of pumps can be affected by the drug being delivered. • Concentration, molecular size, and corrosion of pump materials can have serious effects • Clinical trial results indicate that the Prometra Pump is very accurate when delivering morphine sulfate • Experience with both Infumorph® and compounded morphine at a wide range of concentrations • What about other drugs? • Accuracy should be unaffected by the type of drug in the pump.1 • The titanium dosing chamber of the Prometra Pump simply measures the exact volume of the fluid to be delivered. • This measurement is unaffected by type of fluid in the chamber 1Yearwood, T. Results of Secondary Pain Medications to Improve Pain Outcomes in The Prometra Programmable Infusion Pump. Poster Presentation at the 11th Annual ASRA Pain Medicine Meeting, November 2012

  21. Clinical Significance? • Scheduling of refill visits • Possibly avoiding overdose/underdose, withdrawal symptoms • Drug dependent • Micro-dosing • Future applications

  22. Intracranial Drug Administration ICV Intraparenchymal (IPa) Intracerebroventricular (ICV) IT

  23. Clinical Need for Accuracy in Drug Delivery to the Brain • limit exposure to other organs • deliver complex dosing pattern • greatly reduce effective drug dosage

  24. Conclusions • Achieved design goals • 98% accurate, independent of external factors • Confirmed in bench tests • Validated in clinical trials • Clinical significance depends on disease/drugs

More Related